DaVita Inc. (LON:0I7E)
142.83
-2.64 (-1.81%)
At close: Feb 21, 2025
DaVita Revenue
In the year 2024, DaVita had annual revenue of $12.82B USD with 5.56% growth. DaVita had revenue of $3.29B in the quarter ending December 31, 2024, with 4.73% growth.
Revenue
$12.82B
Revenue Growth
+5.56%
P/S Ratio
n/a
Revenue / Employee
$168.63K
Employees
76,000
Market Cap
9.01B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 12.82B | 675.40M | 5.56% |
Dec 31, 2023 | 12.14B | 530.25M | 4.57% |
Dec 31, 2022 | 11.61B | -8.90M | -0.08% |
Dec 31, 2021 | 11.62B | 68.19M | 0.59% |
Dec 31, 2020 | 11.55B | 162.13M | 1.42% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 43.19B |
GSK plc | 31.38B |
Haleon | 11.24B |
Smith & Nephew | 4.46B |
Hikma Pharmaceuticals | 2.39B |
ConvaTec Group | 1.74B |
HUTCHMED (China) | 483.31M |
Genus | 668.80M |
DaVita News
- 3 days ago - Berkshire Hathaway further trims DaVita stake - Seeking Alpha
- 3 days ago - Berkshire Hathaway sells another 750,000 DaVita shares - Reuters
- 5 days ago - DaVita Inc (DVA) Celebrates Record Participation in Annual Fundraising Event - GuruFocus
- 6 days ago - Here’s why this Warren Buffett stock plunged 11% in a day - Finbold
- 8 days ago - DaVita (DVA) Stock Drops Following Earnings Report and Stake Reduction - GuruFocus
- 8 days ago - Why DaVita Inc Stock Is Plummeting Today - The Motley Fool
- 8 days ago - DaVita (DVA) Stock Declines Amid Weak Q4 Results - GuruFocus
- 8 days ago - DaVita's stock leads S&P 500 decliners after Berkshire pares stake. Its soft guidance isn't helping. - Market Watch